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Studies of racial disparities in patients admitted with an OHCA in the setting of AMI have 
shown inconsistent results. Whether these differences in care exist in a universal healthcare 
system in England is unknown.  
Methods: 
Patients admitted with a diagnosis of AMI and OHCA between 2010 to 2017 from the 
Myocardial Ischaemia National Audit Project (MINAP) were studied. All patients were 
stratified based on ethnicity into Black, Asian, and Minority Ethnic (BAME) group versus 
White group. We used multivariable logistic regression models to evaluate the predictors of 
clinical outcomes and treatment strategy. 
Results: 
From 14,287 patients admitted with AMI complicated by OHCA, BAME patients constituted 
a minority of patients (1,185(8.3%)) compared to White group (13,102(91.7%)). BAME 
patients were younger (BAME median age (IQR) 58(50-70) years, White group median age 
(IQR) 65(55-74) years). Cardiogenic shock (BAME 33%, White group 20.7%, p <0.001) and 
severe LV impairment (BAME 21%, White group 16.5%, p 0.003) were more frequent among 
BAME patients. BAME patients were more likely to be seen by a cardiologist (BAME 95.9%, 
White group 92.5%, p <0.001) and were more likely to receive coronary angiography than the 
White group (OR 1.5, 95% CI 1.2-1.88). The BAME group had significantly higher in-hospital 
mortality (OR 1.26, 95%CI 1.04-1.52) and re-infarction (OR 1.52, 95%CI 1.06-2.18) than the 
White group. 
Conclusion: 
BAME patients were more likely to be seen by a cardiologist and receive coronary angiography 
than White group. Despite this, the in-hospital mortality of BAME patients, particularly the 












Most studies of racial disparities in AMI with OHCA used data from the United States, with a 
lack of studies in Europe and United Kingdom. We used the Myocardial Ischaemia National 
Audit Project (MINAP) to study the racial disparities on care and outcomes of AMI with 
OHCA between 2010 and 2017. While BAME patients were more likely to receive coronary 
angiography than the White group, the in-hospital mortality of BAME patients, particularly the 































Out-of-hospital cardiac arrest (OHCA) is a major cause of cardiovascular mortality1,2. 
Approximately 275,000 persons experience OHCA in Europe annually, with only 29,000 
persons surviving to hospital discharge3. Ethnicity is an important factor in determining an 
individual’s place of residence, socioeconomic status, and access to cardiopulmonary 
resuscitation in the community, factors which are known to be associated with significant 
variation in the response to and outcomes of OHCA 4,5.  
While many studies have assessed racial differences in the care of  OHCA complicated by 
an AMI, the results have been inconsistent 6–9. Some studies suggested that clinical outcomes 
were worse in the ethnic minorities compared to the White population 6,7,10. These studies 
attributed these racial disparities to various factors that affect community response, such as 
socioeconomic status, lack of awareness in recognition of symptoms, delay in seeking early 
medical help, and implicit bias from the treating physicians4,5. For instance, a meta-analysis of 
racial disparities in outcomes of OHCA complicating AMI in the United States showed that 
Black population have worse outcomes than the White populations 6.  Most studies of racial 
disparities in AMI with OHCA used data from the United States (US), with a lack of studies 
that examined OHCA characteristics and survival in Europe and United Kingdom6. Data from 
the United Kingdom can give additional insights on the impact of racial disparities because of 
differences in population structure compared to the United States, and the availability of a 
universal healthcare access through the National Health Service (NHS). The NHS is a universal 
public sector system that provides universal access to health services to the whole population 
independent of their socioeconomic status. In contrast, access to United States healthcare 
systems and the quality of care received depend, to a greater extent, on patient’s socioeconomic 
status and their medical insurance coverage. This means  that individuals in the lower 
socioeconomic strata of society are unable to afford health care expenses despite large 
governmental expenditure, disproportionately placing the Black population at a disadvantage 
11,12. 
We used the Myocardial Ischaemia National Audit Project (MINAP), a national registry 
of AMI hospitalization in England and Wales, to study the impact of patients’ ethnicity on the 
processes of care, and clinical outcomes of patients admitted with AMI complicated by OHCA 










The MINAP is a national cardiac audit that collects information around the  presenting 
profile and clinical care of patients hospitalised with diagnosis of AMI in England 13–15. The 
data collected are utilised for auditing quality of care and public reporting of  AMI patients and 
also provides a resource for academic research 12,14,16. The database contains information about 
patient demographics, admission time and method, cardiovascular comorbidities, clinical 
characteristics, relevant investigations, in-hospital pharmacological and interventional 
treatments, in-hospital outcomes and discharge treatments 15,17. 
 
Study population 
The cohort for this study included all patients aged >18 years, admitted with a final 
diagnosis of AMI (either STEMI or non-ST-segment myocardial infarction (NSTEMI)) and 
OHCA between January 1, 2010 and March 31, 2017. The discharge diagnosis of AMI was 
established by the treating clinician according to the presenting history, clinical examination, 
and the results of inpatient investigations based on the consensus document of the Joint 
European Society of Cardiology and American College of Cardiology18. The total number of 
patients diagnosed with AMI was 664,740. Of those, the number of patients who didn’t present 
with OHCA was 511,329 patients. Patients with missing data including ST elevation on 
presentation (41,124 patients), ethnicity (55,153 patients), cardiac arrest site (22,140 patients), 
and in-hospital mortality information (20,707 patients) were excluded from the analysis. The 
final number of patients included in the cohort was 14,287 patients (Supplementary figure S1).  
MINAP define the patient's ethnic group based on patient self- reporting based on 
categories used to capture race that are used nationally in this and other national electronic 
health records. All patients were stratified into two groups based on the ethnicity into Blacks, 
Asians, and Minority Ethnic (BAME) group versus Whites ethnicity group. The BAME group 
included those whose race was recorded as Blacks (including Caribbean, African, Black 
British, and any other Blacks background), Asians (including Indian, Pakistani, Bangladeshi, 
Asian British, any other Asian Background – but excluding Chinese) and other Non-Whites 
ethnicity (including Chinese). We collected detailed information on patient characteristics, 
clinical presentations, comorbidities, and discharge pharmacology. The outcomes of interest 
were in-hospital mortality, re-infarction, major bleeding, and utilization of coronary 











Ethical approval was not required for this study under current arrangements by the 
National Health Service (NHS) research governance because MINAP database was collected 
and used for research purposes without informed patient consent by the National Institute for 




MINAP tackles oversight by providing guidance and technical advice for staff entering 
data via a dedicated helpdesk, and consistently by using error-checking routines in MINAP 
data application. The completeness of 20 key fields is closely monitored and is generally above 
95%. These fields include NHS number, discharge diagnosis, hospital mortality and secondary 
prevention medication prescribed at discharge. A data validation exercise is done annually and 
requires every hospital to re-enter 20 data items from the medical records of 20 randomly 
selected patients, using a specially designed data validation tool16. 
 
Statistical analysis 
We described the baseline characteristics as number and percentage for categorical 
variables, and as median and interquartile range (IQR) for continuous variables. Chi-square 
test and t-test were used to test for statistical significance between categorical and continuous 
variables respectively. The Kruskal Wallis test was used for skewed data. We used multiple 
imputation techniques with chained equations to account for the missing data. Age, sex, 
ethnicity, clinical diagnosis, and in-hospital mortality were registered as regular variables in 
the imputations model, while all other variables, including body mass index, seen by 
cardiologists, left ventricular (LV) systolic function, previous percutaneous coronary 
intervention (PCI), coronary artery bypass graft (CABG), heart failure, hypercholesterolemia, 
angina, cerebrovascular disease, peripheral vascular disease, creatinine levels, diabetes, 
hypertension, smoking status, asthma or COPD, family history of coronary disease, in-hospital 








angiotensin-converting enzyme inhibitor were imputed  (Supplementary table S1). The 
variable selection in the model was based on previous studies using the MINAP registry and 
prior clinical knowledge 14. Using these models, 10 imputed datasets were generated which 
were used to perform all the analyses. Multivariable logistic regression models were used to 
study the association between ethnicity and clinical outcomes. We undertook a sensitivity 
analyses to compare and contrast clinical characteristics, management strategies and clinical 
outcomes amongst Black population, Asian population, other Non-Whites ethnic minority 
(Other) and used the White group as a reference.  All models included the same variables used 
in the multiple imputation models as well as the year of admission. Estimates in the form of 
odds ratios (ORs) and 95% confidence intervals (95% CIs) were reported. Statistical 
significance was considered with an alpha of 0.05 in all the 2-sided tests used. Stata version 




From 14,287 patients admitted with AMI complicated by OHCA, BAME patients 
constituted the minority of patients (8.3%). BAME patients were younger (BAME median age 
(IQR) 58(50-70) years, White group median age (IQR) 65(55-74) years) with a lower 
proportion of females (BAME 18.0%, White group 23.2%, p<0.001). Cardiogenic shock 
(BAME 33%, White group 20.7%, p <0.001) and severe LV impairment (BAME 21%, White 
group 16.5%, p 0.003) was more frequent amongst BAME patients. Cardiometabolic risk 
factors were more prevalent in BAME patients than White group patients, particularly diabetes 
(BAME 31%, White group 13%, p <0.001), hypertension (BAME 48%, White group 41%, 
p<0.001), hypercholesterolemia (BAME 35%, White group 26%, p<0.001), heart failure 
(BAME 6.5%, White group 4.6%, p =0.008), and chronic kidney disease (BAME 5.2%, White 
group 3.8%, p =0.024). Table 1 shows the patients' characteristics and clinical presentation of 
AMI patients with OHCA. The proportion of AMI patients with OHCA from the BAME group 
tripled from around 4% in 2010 to 12% in 2017 (figure 1).  
 








BAME patients were more likely to be seen by a cardiologist (BAME 95.9%, White 
group 92.5%, p <0.001), receive coronary angiography (BAME 88%, White group 79.6%, p 
<0.001), and receive PCI (BAME 45%, White group 39.5%, p =<0.001). Administration of 
dual antiplatelet therapy (BAME 75.6%, White group 77.6%, p =0.12) and most of the other 
evidence-based medication like beta blockers (BAME 70.2%, White group 70.1%, p =0.93) 
and fondaparinux (BAME 11.9%, White group 14.1%, p =0.054) in BAME group was 
relatively similar to the White group as illustrated by table 2. However, ACEI (BAME 59.9%, 
White group 54.7%, p =0.002) were more commonly administered in the BAME group 
whereas statins (BAME 55%, White group 58.2%, p =0.034) were more commonly 
administered in the White group. After adjusting for baseline risk factor differences, BAME 
group were more likely to receive coronary angiography than the White group (OR 1.5, 95%CI 
1.2-1.88) (Supplementary table S2). 
 
Clinical outcomes: 
The BAME group had higher crude in-hospital mortality (BAME 31.2%, White group 
26.6%, p<0.001) and re-infarction (BAME 3.6%, White group 2.3%, p =0.008) rates than the 
Whites group. The bleeding rate was not significantly different between the two groups 
(BAME 2.8%, White group 3.1%, p =0.63). The crude in-hospital mortality in White group 
has not changed over the last decade, in contrast, in-hospital mortality in BAME patients 
doubled from around 16% in 2010 to around 30% in 2017 (figure 2). 
After adjusting for the comorbidities and in-hospital management, BAME group had 
significantly higher in-hospital mortality (OR 1.26, 95%CI 1.04-1.52) and re-infarction (OR 
1.52, 95%CI 1.06-2.18) than the White group as shown in table 3. 
 
Sensitivity analysis: 
We did a sensitivity analysis to compare the clinical characteristics, management 
strategies and clinical outcomes amongst Black population, Asian population, other Non-
Whites ethnic minority (Other) and used the White group as a reference. Clinical characteristics 
for each ethnic group are presented in supplementary table S3, whereas pharmacotherapy, 
management strategies, and crude in-hospital clinical outcomes in supplementary table S4. 








of coronary angiography (OR 1.5, 95% CI 0.84-2.77) were similar to the White population. In 
contrast, in-hospital death was higher in the Asian population (OR 1.4, 95% CI 1.1-1.78). Table 
4 shows the clinical outcomes of the individual racial groups that make up the BAME group.  
 
Discussion: 
In this national cohort of AMI patients presenting with OHCA, BAME patients were 
younger, had a relatively higher risk comorbidity profile, and were sicker at the time of 
presentation with a greater frequency of STEMI, cardiogenic shock, and severe left ventricular 
impairment compared to the White population. BAME patients also had a relatively higher 
frequency of cardiovascular comorbidities like diabetes, hypertension, and history of previous 
PCI. Administration of evidence-based medications and processes of care in BAME patients 
were often better, with BAME patients more likely to be seen by a cardiologist and to receive 
coronary angiography than the White population. Despite this, the in-hospital mortality of 
BAME patients was significantly higher than their White counterparts, with the worst outcomes 
seen in the Asian population.  
Notably, BAME patients often had better administration of evidence-based medications 
and process of care compared to the White population. The BAME population were much 
younger than the White population, sicker at time of presentation, and with higher prevalence 
of cardiovascular risk factors. This might have encouraged physicians to adopt a more invasive 
approach for management of the BAME patients. Furthermore, BAME patients were more 
likely to present with STEMI, which may also contribute to higher rates of coronary 
angiography use in this patient population. The MINAP registry does not capture data around 
optimization to target which is an important component of quality of care, and so cannot inform 
whether there are significant differences in the patient groups studied 
Previous studies on the link between ethnicity and in-hospital management of OHCA 
revealed that ethnic minorities had lower rate of inpatient cardiac procedures compared to 
Whites. For instance, a registry study from the Los Angeles County Emergency Medical 
Services system in 2019 revealed that minority groups, particularly the Black and Asian 
populations, had a lower frequency of in-hospital interventions like the coronary angiography 
and PCI 20. Groeneveld et al examined the rates of cardiac procedure utilization and long-term 
survival after cardiac arrest. Their study showed that the Black population was less likely to 








with OHCA from England and Wales, we report that BAME patients had better access to some 
aspects of the inpatient management like receiving cardiologist input and use of coronary 
angiography and PCI. These findings suggest that in contrast to the studies performed in the 
United States, there are no significant racial disparities in the in-hospital management of AMI 
patients presenting with OHCA, and that the differences in the in-hospital processes of care 
might not contribute to the lower survival rate reported in BAME patients in the United 
Kingdom. 
The low survival rates in BAME patients reported in the earlier studies from the United 
States were attributed to different factors related to the community response like delayed 
identification of OHCA,  longer response time, lack of awareness about OHCA management, 
and the socioeconomic factors along with other social determinants of health 22–24. To the best 
of our knowledge, this is the first national study from Europe to address the racial disparities 
in management and outcomes of AMI complicated by OHCA. Our study shows that the crude 
mortality rates in BAME population doubled over the study period in contrary to the White 
population where the in-hospital mortality rate remained relatively stable. Despite being 
younger and having similar in-hospital care compared to the White population, BAME patients 
had higher odds of in-hospital death. The survival following OHCA depends to a great extent 
on a “chain of survival” that begins by early recognition of OHCA and activation of the 
emergency response system; cardiopulmonary resuscitation (CPR); defibrillation; advanced 
life support, and integrated care after OHCA25. The efficiency of this chain of survival is linked 
to socioeconomic status and neighbourhood characteristics4,5. For example, Sasson et al 
analyzed a large cohort from the CARES registry in the United States and found that patients 
who had an OHCA in low-income Blacks’ neighborhoods were less likely to receive bystander-
initiated CPR than those in high-income Whites neighborhoods4. Likewise, a recent study 
revealed that patients with low socioeconomic status receive delayed cardiopulmonary 
resuscitation5. The socioeconomic status and level of education were also linked to the CPR 
training disparities, with the White population being trained in CPR more frequently than 
BAME minorities26,27. As BAME patients tend to have lower socioeconomic status and live in 
lower income neighbourhood compared to the White population in the United Kingdom28, they 
have a higher risk of delayed OHCA identification, less efficient chain of survival, and 
subsequently worse clinical outcomes. Moreover, neighbourhoods with higher incidence of 
OHCA and low bystander CPR had a greater proportion of population from ethnic minorities 








providing training on CPR and defibrillators to the BAME community members, ensuring 
adequate availability of defibrillators in the neighbourhoods, and engaging the community 
centres and leaders in improving the community awareness about the importance of the pre-
hospital management of OHCA.     
Our subgroup analysis showed that the Black population had similar survival rate and 
revascularization rate to the White population, but the Asian population had higher risk of in-
hospital death and higher rates of coronary angiography and revascularization than the White 
population. In contrast to our results, Shah et al study on the outcomes of OHCA in South 
Asian population revealed that the quality of care and admission to survival rates in the South 
Asian group were comparable to the White population30. While the reasons behind the lower 
survival rates we reported in the Asian group cannot be fully explained by this study, especially 
with the small number of Black and Asian patients in the MINAP registry, clinicians and policy 
makers may be interested in studying the pre-hospital factors that may be contributing to the 
lower survival rate in the Asian population as a step forward to reduce mortality in this group.  
One of the main strengths of this study is that we are able to study whether there are racial 
disparities in the management and outcomes of AMI presenting with OHCA from a national 
registry in which the data were collected prospectively over a long period of time. This study 
also has limitations that should be considered when interpreting the results. First, as the MINAP 
registry is an in-hospital AMI registry, it only captures OHCA that complicates AMI and 
patients who survived to hospital admission. It provides no insight into outcomes of other types 
of OHCA, which may also have racial disparities. Second, the MINAP database lacks 
information regarding long term mortality and other outcomes and does not capture the 
appropriateness of treatment decisions related to coronary angiography and inpatient 
management nor adherence and optimal titration of evidence-based medications. There are no 
data related to intensive care management like post resuscitation cooling and ventilation. 
Finally, the MINAP registry does not provide any insight into the time to return of spontaneous 
circulation of OHCA in the community, or the management and quality of care prior to hospital 
admission. MINAP does not capture whether differences in the processes of care between both 
study groups is attributable to a higher prevalence of contra-indications to coronary 
angiography in the White group. Although MINAP provide an insight about the neurologic 
deficit immediately after the OHCA, it doesn’t include information about the long-term 








To conclude, BAME patients are increasingly presenting with AMI complicated by 
OHCA and have significantly higher in-hospital mortality compared to the White population 
despite of the consistent inpatient management. The differences in the community response 
and neighborhood characteristics that interfere with the chain of survival in BAME patients 
should be studied and addressed in order to close the gap in the in-hospital survival between 
the BAME and White population. 
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Table 1: Patients' characteristics and clinical presentation of AMI patients with OHCA 
Level White BAME p-value 
N 13102 1185 
 
Age (years), median (IQR) 65.0 (55.0, 74.0) 58.0 (50.0, 70.0) <0.001 
Women 3045 (23.2%) 213 (18.0%) <0.001 
BMI, median (IQR) 26.9 (24.0, 30.2) 26.3 (23.2, 29.5) 0.35 
Clinical diagnosis 
   
STEMI 10027 (76.5%) 973 (82.1%) <0.001 
NSTEMI/UA 3075 (23.5%) 212 (17.9%) 
 
Site of infarction 
   
anterior 4298 (48.2%) 493 (55.5%) <0.001 
inferior 3074 (34.4%) 246 (27.7%) 
 
posterior 492 (5.5%) 38 (4.3%) 
 
lateral 450 (5.0%) 48 (5.4%) 
 
indetermined 610 (6.8%) 63 (7.1%) 
 
Killip class 
   
Killip class I 5357 (62.4%) 434 (49.9%) <0.001 
Killip class II 1020 (11.9%) 97 (11.2%) 
 
Killip class III 427 (5.0%) 44 (5.1%) 
 
Killip class IV (shock) 1781 (20.7%) 294 (33.8%) 
 
LV function 
   
Good * 2720 (26.2%) 248 (25.7%) 0.003 
Moderate 3315 (31.9%) 296 (30.7%) 
 




94.0 (78.0, 116.0) 97.0 (81.0, 
126.0) 
0.11 
Elevated cardiac enzymes 11176 (97.1%) 939 (93.2%) <0.001 
Angina pectoris 1636 (14.4%) 162 (15.4%) 0.41 
Previous MI 1982 (17.3%) 199 (18.8%) 0.22 
Diabetes 1614 (13.4%) 334 (30.8%) <0.001 
Hypertension 4649 (40.6%) 511 (48.2%) <0.001 
Hypercholesterolemia 2934 (26.1%) 365 (35.1%) <0.001 
Smoking 
   
Never  3989 (37.4%) 527 (53.6%) <0.001 
Ex-smoker 2613 (24.5%) 145 (14.7%) 
 
Smoker 4056 (38.1%) 312 (31.7%) 
 
FH of coronary artery 
disease 
2226 (23.8%) 167 (18.4%) <0.001 
Previous PCI 883 (7.7%) 134 (12.7%) <0.001 








Stroke 713 (6.3%) 75 (7.1%) 0.28 
Peripheral vascular disease 453 (4.0%) 20 (1.9%) <0.001 
Heart failure 525 (4.6%) 68 (6.5%) 0.008 
Chronic kidney disease 429 (3.8%) 54 (5.2%) 0.024 
Asthma/COPD 1378 (12.1%) 94 (8.9%) 0.002 
* LV function assessment is based of ejection fraction measurement on transthoracic echocardiography 
BAME=black, Asian, and minority ethnic, , COPD= chronic obstructive pulmonary disease, CABG= 
coronary artery bypass graft, FH= family history, IQR= Interquartile range, LV= left ventricle, MI= 
myocardial infarction, PCI= percutaneous intervention, SD= standard deviation, STEMI: ST elevation 




















































Table 2: Processes of care and unadjusted clinical outcomes of AMI patients with OHCA 
Level White BAME p-value 
N 13102 1185 
 
Seen by cardiologist 11950 (92.5%) 1123 (95.9%) <0.001 
LMWH 5379 (50.0%) 430 (43.9%) <0.001 
Unfractionated heparin 4497 (42.1%) 378 (38.7%) 0.044 
Fondaparinux 1507 (14.1%) 115 (11.9%) 0.054 
Aspirin 11674 (93.4%) 1075 (94.8%) 0.069 
GP IIIa/IIb inhibitors 1716 (15.7%) 161 (16.3%) 0.64 
P2Y12 inhibitors 10064 (81.8%) 881 (80.3%) 0.21 
DAPT 9700 (77.6%) 857 (75.6%) 0.12 
Furosemide 3066 (28.8%) 272 (28.4%) 0.78 
Oral beta blockers 7471 (70.1%) 682 (70.2%) 0.93 
Discharged on beta blockers 7201 (56.8%) 629 (53.9%) 0.053 
ACEI 5915 (54.7%) 584 (59.9%) 0.002 
Statins 7371 (58.2%) 643 (55.0%) 0.034 
Coronary angiography 10031 (79.6%) 1013 (88.2%) <0.001 
PCI 3707 (39.5%) 412 (45.4%) <0.001 
CABG 368 (3.9%) 34 (3.7%) 0.80 
In-hospital death 3491 (26.6%) 370 (31.2%) <0.001 
Re-infarction 286 (2.3%) 40 (3.6%) 0.008 
Bleeding 397 (3.1%) 33 (2.8%) 0.63 
CABG= coronary artery bypass graft, DAPT= Dual antiplatelet therapy, IQR= Interquartile range, LV= left 
ventricle, MI= myocardial infarction, PCI= percutaneous intervention, SD= standard deviation, STEMI: ST 























In-hospital death Reference 1.26(1.04-1.52) 
Re-infarction Reference 1.52(1.06-2.18) 




































In-hospital death Reference 0.88(0.52-1.51) 1.4(1.10-1.78) 1.17(0.85-1.62) 
Re-infarction Reference 2.1(0.89-1.5) 1.79(1.17-2.73) 0.8(0.34-1.8) 
Bleeding Reference 0.7(0.21-2.2) 1.05(0.67-1.66) 0.67(0.32-1.37) 
Receipt of coronary 
angiography 





























Figure 1: Proportion of AMI patients with OHCA from BAME ethnicity 
Figure 2: Crude in-hospital mortality rate of AMI patients with OHCA from BAME ethnicity 
Figure 3: Independent predictors of in-hospital mortality of white and BAME patients 
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